Cargando…

TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury

Cardiovascular and renal inflammation induced by Aldosterone (Aldo) plays an important role in the pathogenesis of hypertension and renal fibrosis. Toll-like receptor 4 (TLR4) signaling contributes to inflammatory cardiovascular and renal diseases, but its role in Aldo-induced hypertension and renal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yide, Peng, Weisheng, Ao, Xiang, Dai, Houyong, Yuan, Li, Huang, Xinzhong, Zhou, Qiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640881/ https://www.ncbi.nlm.nih.gov/pubmed/26556241 http://dx.doi.org/10.1371/journal.pone.0142456

Ejemplares similares

The Toll-like receptor 4 antagonist TAK-242 protects against chronic pancreatitis in rats
por: Pan, Long-Fei, et al.
Publicado: (2017)

TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice
por: Hua, Fang, et al.
Publicado: (2015)

TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
por: Feng, Yan, et al.
Publicado: (2023)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency
por: Fukushima, Hidehiko, et al.
Publicado: (2020)

Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress
por: Gárate, Iciar, et al.
Publicado: (2014)

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2018)

Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
por: Fan, S., et al.
Publicado: (2020)

Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
por: Samarpita, Snigdha, et al.
Publicado: (2020)

TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
por: Ono, Yuko, et al.
Publicado: (2020)

Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
por: Fellner, Avi, et al.
Publicado: (2017)

Sulfonamide Prodrugs with a Two-Stage Release Mechanism for the Efficient Delivery of the TLR4 Antagonist TAK-242
por: Kostyo, Jessica H., et al.
Publicado: (2022)

TAK-242, a novel Toll-like receptor 4 signal transduction inhibitor, protects mice in Escherichia coli-induced and lipoteichoic acid-induced lethality models
por: Ii, M, et al.
Publicado: (2006)

TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis
por: Liu, Sujie, et al.
Publicado: (2022)

TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipidinduced inflammation and insulin resistance in muscle cells
por: Hussey, Sophie E., et al.
Publicado: (2012)

TAK242 suppresses the TLR4 signaling pathway and ameliorates DCD liver IRI in rats
por: Zhong, Xiang, et al.
Publicado: (2019)

TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity
por: Moser, V. Alexandra, et al.
Publicado: (2018)

Prenatal exposure to TAK242 affects the childhood autism in offspring in animal models of autism spectrum disorder
por: Xu, Xiaoyan, et al.
Publicado: (2017)

TAK-242 ameliorates epileptic symptoms in mice by inhibiting the TLR4/NF-κB signaling pathway
por: Dong, Jibo, et al.
Publicado: (2022)

TAK-242 protects against oxygen-glucose deprivation and reoxygenation-induced injury in brain microvascular endothelial cells and alters the expression pattern of lncRNAs
por: Kong, Li-Yun, et al.
Publicado: (2023)

Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242
por: Wu, Chuangyan, et al.
Publicado: (2017)

TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway
por: Wang, Jiajia, et al.
Publicado: (2020)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
por: Fujihara, Clarice K., et al.
Publicado: (2017)

Natural Products with Toll-Like Receptor 4 Antagonist Activity
por: Molteni, Monica, et al.
Publicado: (2018)

A new model to predict acute kidney injury after cardiac surgery in patients with renal insufficiency
por: Wang, Xijian, et al.
Publicado: (2022)

Aldosterone receptor antagonists: current perspectives and therapies
por: Guichard, Jason L, et al.
Publicado: (2013)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
por: Younan, Patrick, et al.
Publicado: (2017)

Health Tract, No. 242: Emergencies
Publicado: (1866)

Modeling of the Toll-like receptor 3 and a putative Toll-like receptor 3 antagonist encoded by the African swine fever virus
por: Henriques, Elsa S, et al.
Publicado: (2011)

CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK–779
por: Nedjai, Belinda, et al.
Publicado: (2015)

Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
por: Banki, Nora F., et al.
Publicado: (2012)

Albumin Level at Admission to the Intensive Care Unit Is Associated With Prognosis in Cardiac Arrest Patients
por: Li, Yide, et al.
Publicado: (2021)

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China
por: Guo, Naifeng, et al.
Publicado: (2019)

Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth
por: Chin, Peck Yin, et al.
Publicado: (2016)

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
por: Zhao, Jing, et al.
Publicado: (2021)

Suppression of Aldosterone Synthesis and Secretion by Ca(2+) Channel Antagonists
por: Ikeda, Keiichi, et al.
Publicado: (2012)

Use of Aldosterone Antagonist to Treat Diarrhea and Hypokalemia of Ogilvie's Syndrome
por: Ram, Pradhum, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vb2ic89di2o5e9t7eps746aj3v